Everest Organics Ltd

Everest Organics Ltd (EVERESTO) is a micro-cap Healthcare company valued at ₹243 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Everest Organics Ltd last traded at ₹250, sharply up 9.82% on the day.

Recent developments

On 2026-09-30, promoter holding increased by 1.01 percentage points to 60.61%, indicating a strengthening of control. In the latest quarter, the company reported a net profit of ₹1 crore, which was flat compared to the same quarter a year earlier.

Financial performance

The company's annual revenue rose 23.0% to ₹196 crore, but its latest quarter revenue fell 10.0% year-on-year to ₹48 crore. Net profit swung from a loss of ₹1 crore to a profit of ₹6 crore annually, with the net profit margin improving 3.6 percentage points to 2.8%. However, the latest quarter net profit dropped 21.3% to ₹1 crore.

Valuation multiples

The stock trades at 43.9 times earnings, a premium to the Healthcare median of 32.0, 3.45 times book value. It yields 0.2%.

Things to watch

The stock is 57.6% below its 52-week high, reflecting a significant decline from recent peak levels. The latest quarter revenue fell 10.0% year-on-year, and the net profit margin, while improved, remains low at 2.8%. The company's profit has declined 16.9% annually over the past five years.

Where it stands

Everest Organics Ltd ended the latest quarter with revenue of ₹48 crore and a net profit of ₹1 crore, showing a flat net profit but a decline in revenue compared to the same quarter a year earlier. The company's promoter holding increased slightly, but its profit growth has slowed significantly over the past five years, with the stock trading far below its 52-week high.

Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.